Financing
Payment of Deferred Purchase Consideration
Amgen Payment of Deferred Purchase Consideration decreased by 13.0% to -$104.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 285.2%, from -$27.00M to -$104.00M.
Analysis
StatementCash Flow Statement
SectionFinancing
First reportedQ1 2013
Last reportedQ1 2026Apr 30, 2026
Metric ID:
isrg_payment_of_deferred_purchase_considerationHistorical Data
16 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$33.00M | -$19.00M | -$26.00M | -$26.00M | -$61.00M | $0.00 | -$28.00M | -$53.00M | -$5.00M | -$90.00M | -$40.00M | $0.00 | -$2.00M | -$27.00M | -$92.00M | -$104.00M |
| QoQ Change | — | +42.4% | -36.8% | +0.0% | -134.6% | +100.0% | — | -89.3% | +90.6% | <-999% | +55.6% | +100.0% | — | <-999% | -240.7% | -13.0% |
| YoY Change | — | — | — | +21.2% | -221.1% | — | -7.7% | -103.8% | — | -221.4% | +24.5% | — | +60.0% | +70.0% | -130.0% | -285.2% |
Range-$104.00M – $0.00
CAGR+35.8%
Avg YoY Growth-79.3%
Median YoY Growth-55.8%
Current Streak3 quarters decline
Payment of Deferred Purchase Consideration at Other Companies
Frequently Asked Questions
- What is Amgen's payment of deferred purchase consideration?
- Amgen (AMGN) reported payment of deferred purchase consideration of -$104.00M in Q1 2026.
- How has Amgen's payment of deferred purchase consideration changed year-over-year?
- Amgen's payment of deferred purchase consideration decreased by 285.2% year-over-year, from -$27.00M to -$104.00M.